Measuring the Pulse of 2016
Exhibiting renewed confidence, the Indian healthcare sector is poised to break growth barriers in 2017 given a favourable policy environment and challenges that only seem to further strengthen the industrys resolve to enhance quality to become competitive globally. Elets News Network (ENN) takes a look at how 2016 shaped up for the Indian healthcare sector and how some of the newsmakers in the industry pushed the quality of healthcare delivery in the country to the next level.
The bygone year was an action-packed year for the Indian Healthcare industry. Exhibiting strong confidence in their capabilities to scale new heights, several Indian healthcare companies in pharmaceutical, diagnostics businesses, multispecialty hospital chains, an oncology chain, successfully rode the primary market wave by launching their initial public offerings (IPOs).

The acquisition and merger scenario, too, saw a lot of action happening with Chinas Shanghai Fosun Pharmaceutical Co striking a $1.4-billion deal with Gland Pharma Limited to acquire 86 per cent stake in the Hyderabad- based company.

The high growth potential of healthcare delivery companies generated a high level of interest among private equity firms, as several Indian pharma majors closed strategic deals in domestic as well as overseas market.
The single-specialty sector including hospital chains in eye care, mother and child care, dental care and oncology segments attracted good investments, even as multispecialty hospital chains like Hyderabad-based CARE Hospitals raised funds to further their expansion plans to improve healthcare delivery across the country.

The end of regulatory uncertainty with regard to in-vitro fertilisation (IVF) also significantly improved investment environment with PE investments beginning to flow into the promising segment.

The Indian healthcare tech startups continued to show traction with 73 deals worth over $113 million struck, highlighting the future potential of disruptive thinking in healthcare delivery.
Despite facing opposition, online pharmacies, too, attracted significant investments as the government initiated the process of setting clear regulatory guidelines to regulate them.
KEY IPOS IN HEALTHCARE SECTOR | ||
Name of Company | Name of Company | Result |
Syngene International | र 550-cr | Over-subscribed 32 times |
Dr Lal PathLabs | र 638-cr | Over-subscribed 33 times |
Alkem Laboratories | र 1,350-cr | Over-subscribed 44 times |
Narayana Hrudayalaya | र 613-cr | Over-subscribed 9 times |
Healthcare Global Enterprises | र 357.30-cr | Over-subscribed 2 times |
Thyrocare Technologies | र 479.21-cr | Over-subscribed 73 times |
Laurus Labs | र 1,331.79-cr | Over-subscribed 4.5 times |
MAJOR DEALS IN HEALTHCARE SECTOR |
|
Besides taking cognizance of the big-ticket investments “ both inbound and outbound — and fund raising happening throughout the year, we contacted several captains of the Indian healthcare sector to know what they were able to achieve in 2016. Here is what they shared with us.
![]() Dr Jintendar Kumar Sharma, Director & CEO of the Andhra Pradesh MedTech Zone (AMTZ) Limited and Advisor (Health), Government of Andhra Pradesh KEY ACHIEVEMENTS:
|
![]() Dr Mayank Somani, CEO, Medics Super Speciality Hospital KEY ACHIEVEMENTS:
|
![]() Dr Nand Kumar Jairam, CMD, Columbia Asia Hospitals KEY ACHIEVEMENTS:
|
![]() Dr Shankar Narang, Chief Operating Offi cer, Paras Healthcare KEY ACHIEVEMENTS:
|
![]() Dr Sajan Nair, Group COO, Zydus Hospitals & Healthcare Research Pvt Ltd KEY ACHIEVEMENTS:
|
Neha Rastogi, Co-founder of Agatsa KEY ACHIEVEMENTS:
|
post_id:
uld_count:
Cookie not set
Value 1: 0
Value 2: 10